60 Degrees Pharmaceuticals, Inc.
SXTP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2,932 | $242,369 | $1,623,527 | $1,623,527 |
| - Cash | $1,659 | $2,142 | $265 | $115 |
| + Debt | $156 | $173 | $22,418 | $18,805 |
| Enterprise Value | $1,429 | $240,399 | $1,645,681 | $1,642,217 |
| Revenue | $608 | $254 | $223 | $1,160 |
| % Growth | 139.6% | 13.6% | -80.8% | – |
| Gross Profit | $223 | -$221 | -$209 | $310 |
| % Margin | 36.7% | -87.1% | -93.7% | 26.7% |
| EBITDA | -$7,884 | -$1,427 | -$2,109 | -$1,015 |
| % Margin | -1,297.6% | -562.6% | -944.9% | -87.5% |
| Net Income | -$7,947 | -$3,766 | -$6,182 | -$4,252 |
| % Margin | -1,308% | -1,485.1% | -2,769.5% | -366.4% |
| EPS Diluted | -18.55 | -0.95 | -1.07 | -0.74 |
| % Growth | -1,852.6% | 11.2% | -44.6% | – |
| Operating Cash Flow | -$5,648 | -$4,543 | -$1,010 | -$649 |
| Capital Expenditures | -$181 | -$116 | -$60 | -$35 |
| Free Cash Flow | -$5,829 | -$4,659 | -$1,070 | -$684 |